Categories Earnings, Other Industries

Alaska Air Group (ALK) to report higher revenue and earnings in Q4

Alaska Air Group Inc. (NYSE: ALK) is slated to report fourth quarter 2019 earnings results on Tuesday, January 28, after the market closes. The airline is expected to deliver higher revenue and profits for the quarter versus the year-ago period.

Analysts have estimated earnings of $1.41 per share which compares to EPS of $0.75 reported a year earlier. Revenue is expected to increase 7% year-over-year to $2.22 billion.

Alaska Air Group beats revenue and earnings estimates for Q3 2019

The topline numbers are expected to benefit from strong demand during the quarter. Last quarter, passenger revenue grew 8%. The momentum in traffic and capacity is also likely to push growth during the period. The company reported capacity increases in all three months of the quarter while traffic saw a slight decline in November.

December saw the strongest numbers with a 9.4% growth in traffic and a 4.7% rise in capacity. The results are also likely to benefit from lower fuel costs. Last quarter, economic fuel cost per gallon fell 8.6%. However, higher non-fuel unit costs might dampen the quarterly results.

In the third quarter of 2019, Alaska Air beat revenue and earnings expectations. Revenue increased 8% to $2.34 billion while adjusted EPS jumped 38% to $2.63. RASM was up 4.5% while CASM, ex fuel rose 3.4%.

Shares of Alaska Air have gained 2% in the past one year. The majority of analysts have rated the stock as Buy and it has an average price target of $76.44.

Southwest Airlines (NYSE: LUV), JetBlue Airways (NYSE: JBLU) and American Airlines (NYSE: AAL) all reported their fourth quarter earnings this week. While JetBlue and American beat earnings estimates, Southwest missed profit expectations.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top